Eugia US LLC recalls Eptifibatide injection vials made in India with failed impurities that could pose health risks. Affected units have specific NDC and lot numbers.
Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.
Eugia US LLC is recalling Eptifibatide injection vials due to failed impurities that may cause health risks. This recall affects patients using the medication as prescribed by a doctor.
The injection vials contain a failed impurity identified as Eptifibatide dimer. This impurity could potentially cause health risks when administered as a medication.
Patients prescribed Eptifibatide injection by a doctor are most at risk. The recall applies to specific vial lots manufactured in India.
Check for the NDC number 55150-219-10 and lot number 3EF22003 on the vial label. The vials were manufactured in India and expire June 30, 2025.
Look for NDC 55150-219-10 and lot number 3EF22003 on the vial.
The recall indicates the product has failed impurities that could pose health risks, so it is not safe to use.
The official notice does not specify a remedy, so contact your doctor or the manufacturer for guidance.
The product was manufactured in India with a lot number 3EF22003.
We’ve drafted a message you can send Eugia to request your refund or repair — edit it as you like.
Subject: Recall D-0556-2024 — Eugia Eugia Hello, I own a Eugia that is covered by recall D-0556-2024 from Eugia. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
